| Sex differences in the aging murine urinary bladder and influence on the tumor immune microenvironment of a carcinogen-induced model of bladder cancer A Hamade, D Li, K Tyryshkin, M Xu, G Conseil, P Yolmo, J Hamilton, ... Biology of sex Differences 13 (1), 19, 2022 | 28 | 2022 |
| Anesthetic technique and oncological outcomes in urology: A clinical practice review AJ Lusty, GW Hosier, M Koti, S Chenard, GB Mizubuti, M Jaeger, ... Urologic Oncology: Seminars and Original Investigations 37 (12), 845-852, 2019 | 26 | 2019 |
| Sexual dimorphism in outcomes of non–muscle-invasive bladder cancer: a role of CD163+ macrophages, B cells, and PD-L1 immune checkpoint S Chenard, C Jackson, T Vidotto, L Chen, C Hardy, T Jamaspishvilli, ... European Urology Open Science 29, 50-58, 2021 | 20 | 2021 |
| Innate immune memory is associated with increased disease-free survival in bladder cancer patients treated with bacillus Calmette-Guérin CH Graham, JF Paré, T Cotechini, W Hopman, CCT Hindmarch, ... Canadian Urological Association Journal 15 (8), E412, 2021 | 14 | 2021 |
| Investigating the STING pathway to explain mechanisms of BCG failures in non-muscle invasive bladder cancer: prognostic and therapeutic implications M Koti, S Chenard, S Nersesian, T Vidotto, A Morales, DR Siemens Bladder Cancer 5 (3), 225-234, 2019 | 9 | 2019 |
| Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer N Shakfa, D Li, G Conseil, ED Lightbody, J Wilson-Sanchez, A Hamade, ... Journal for Immunotherapy of Cancer 11 (4), 2023 | 5 | 2023 |
| Atypical B Cells Promote Cancer Progression and Poor Response to Bacillus Calmette-Guérin in Non–Muscle Invasive Bladder Cancer P Yolmo, S Rahimi, S Chenard, G Conseil, D Jenkins, K Sachdeva, ... Cancer immunology research 12 (10), 1320-1339, 2024 | 4 | 2024 |
| The CXCR3alt-CXCL11 axis in bladder cancer: potential for prediction of neoadjuvant chemotherapy response S Chenard, D Robert Siemens, M Koti Cellular & Molecular Immunology 18 (7), 1631-1633, 2021 | 4 | 2021 |
| PTEN and BRCA1 tumor suppressor loss associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in a murine model of … N Shakfa, D Li, G Conseil, E Lightbody, J Wilson-Sanchez, A Hamade, ... bioRxiv, 2022.06. 27.497846, 2022 | 3 | 2022 |
| Atypical B cells mediate poor response to Bacillus Calmette Guérin immunotherapy in non-muscle invasive bladder cancer P Yolmo, S Rahimi, S Chenard, G Conseil, D Jenkins, K Sachdeva, ... | 2 | 2022 |
| Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpoint S Chenard, C Jackson, T Vidotto, L Chen, C Hardy, T Jamaspishvilli, ... bioRxiv, 2021.01. 23.427909, 2021 | 2 | 2021 |
| Chemotherapy–Surgery Interval Effects on Tumor Necrosis and Outcome in Children and Young Adults With Osteosarcoma RB Mersfelder, C Lwin, S Malik, TC Badgett, SW Chenard, A Rekulapelli, ... Pediatric Blood & Cancer, e31466, 2024 | 1 | 2024 |
| Increased stromal densities of B cells, CD103+ cells, and CD163+ M2-like macrophages associate with poor clinical outcomes in BCG treated non-muscle invasive bladder cancer B Ravenscroft, P Yolmo, S Chenard, S Rahimi, K Pace, K Sachdeva, ... bioRxiv, 2023.10. 19.562817, 2023 | 1 | 2023 |
| Carcinogen induced expansion of atypical B cells and pre-treatment tumor adjacent tertiary lymphoid structures associate with poor response to BCG in non-muscle invasive … P Yolmo, S Rahimi, S Chenard, G Consëil, D Jenkins, K Sachdeva, ... bioRxiv, 2022.12. 30.522127, 2022 | 1 | 2022 |
| Improving genotype specific chemotherapy response in ovarian cancer via cGAS-STING pathway activation N Shakfa, E Lightbody, D Li, J Wilson-Sanchez, G Conseil, ... Cancer Research 81 (13_Supplement), 1708-1708, 2021 | 1 | 2021 |
| Distinguishing benign and malignant myxoid soft tissue tumors: Performance of radiomics vs. radiologists JM Lawrenz, C Cui, SR Johnson, KS Hajdu, SW Chenard, A Rekulapelli, ... PloS one 20 (1), e0318072, 2025 | | 2025 |
| MSTT-199: MRI Dataset for Musculoskeletal Soft Tissue Tumor Segmentation T Reasat, S Chenard, A Rekulapelli, N Chadwick, J Shechtel, ... arXiv preprint arXiv:2409.03110, 2024 | | 2024 |
| Prophylactic Antibiotic Choice and Deep Infection in Lower Extremity Endoprosthetic Reconstruction: Comparison of Cefazolin, Cefazolin-Vancomycin, and Alternative Regimens KS Hajdu, SW Chenard, AD Judice, JC Quirion, AP Mika, WB Gilbert Jr, ... JAAOS-Journal of the American Academy of Orthopaedic Surgeons, 10.5435, 2024 | | 2024 |
| ChatGPT provides safe responses to post-operative concerns following total joint arthroplasty SW Chenard, AP Mika, GG Polkowski, SM Engstrom, JM Wilson, ... Current Orthopaedic Practice, 10.1097, 2024 | | 2024 |
| Operating room efficiency of orthopedic surgery during the COVID-19 era S Koester, S Chenard, C Ani, J Moo Young, C Liles, R Dambrino, V Tiwari, ... The American Journal of Managed Care 29 (11), e348-352, 2023 | | 2023 |
